A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population.
Manfred WargenauSibylle ReidemeisterIngrid KlingmannViviane KlingmannPublished in: Therapeutic innovation & regulatory science (2022)
Since the suggested acceptability criteria takes both swallowability and palatability into account as composite endpoint, it is highly sensitive to detect acceptability differences between oral formulations. It is a well-defined valid approach, which meets regulatory requirements in an appropriate and comprehensive manner and may in future serve as a pragmatic, standardized method to assess and compare acceptability of pediatric formulations with active substances.